FEB 05, 2014 5:00 PM PST

Veterinary treatment approaches to common clinical signs in toxicology setting

C.E. Credits: CE
Speaker
  • Attending Veterinarian, Director of LAS , National Shanghai Center for New Drug Safety Evaluation & Research (NCDSER), CHINA
    Biography
      Xueying Pan, Director of Laboratory Animal Service, Attending Veterinarian, NCDSER/Shanghai InnoStar Bio-Tech Co., Ltd., Shanghai, China. Received my master degree from Huazhong Agricultural University in Wuhan City, Hubei Province, China. My major was basic veterinary medicine. Now I am a Ph.D candidate in Shanghai Jiaotong University. My major is preventive veterinary medicine. I have been an IACUC member for six years in NCDSER/ Shanghai InnoStar Bio-Tech Co., Ltd. which is a toxicology CRO and majorly conducts GLP preclinical toxicity studies for clients.

    Abstract

    This presentation mainly includes 4 sections, the first one: introduction for CFDA/FDA GLP Regulation and analysis the difference. The second one: introduction of the most important responsibility of veterinarian, for example: to supply support to scientist, to supply veterinary care promptly, to ensure the animal welfare and enrichment. The third one: The procedure for observation of abnormal animal. The fourth one: case for case, for example, alopecia, dehydration, decrease the consumption of food, not drink water, decrease the activity, diarrhea, mass or tumor. Outline - Requirements for animal welfare and veterinary care in related regulations of toxicology study - Requirement for laboratory animals in CFDA GLP regulations - Requirement for laboratory animals in FDA GLP regulations - Requirement for laboratory animals in OECD GLP regulations - Responsibility of veterinarian in the toxicology study - To supply support to scientist - To supply veterinary care promptly - To ensure the animal welfare and enrichment - The procedure for observation of abnormal animal - Case - Alopecia - Dehydration - Decrease the consumption of food, not drink water - Decrease the activity - Diarrhea - Mass or tumor


    Show Resources
    You May Also Like
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    FEB 26, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    FEB 19, 2020 11:00 AM PST
    C.E. CREDITS
    FEB 19, 2020 11:00 AM PST
    DATE: February 19, 2020TIME: 11:00am PST, 2:00pm EST...
    Loading Comments...
    Show Resources